VYYRF - Voyageur Files Further Updated NI 43-101 Report on the Frances Creek Barite Project
(TheNewswire)
Calgary, Alberta – TheNewswire - December 18, 2020 – VoyageurPharmaceuticals Ltd. (TSXV:VM) USA (OTC : VYYRF) (the "Company" or"Voyageur") is please to announce thefiling of its further updated Frances Creek Barite Project NI 43-101Technical Report (the "Report") on SEDAR. The Reportsupersedes previous NI 43-101 reports filed by the Company on SEDARand dated July 11, 2018 and February 7, 2019. The Report wasco-authored by Craig Dunn, P. Geol. and Murray Lytle, Ph.D., P. Eng.,is entitled "Technical Report: Voyageur Pharmaceuticals Ltd.Frances Creek Barite Early-Stage Exploration Project Radium, BC"and is dated December 18, 2020.
About Voyageur
Voyageur Pharmaceuticals Ltd. is Canadian publiccompany listed on the TSX Venture Exchange under the trading symbolVM. Voyageur is focused on the development of barite, iodine, andfullerene Active Pharmaceutical Ingredient (API) minerals. Thenear-term focus is developing barium, iodine radio-contrast productsand fullerene-based pharmaceutical products.
Voyageur’s goal is to initially generate the positivecash flow from operations using third party GMP pharmaceuticalmanufacturers in Canada and in India. Ultimately, Voyageur has plansto build all the required infrastructure to become 100%self-sufficient with all manufacturing.
Voyageur owns a 100% interest in three barium sulfate(barite) projects including two properties suitable in grade for theindustrial barite marketplace, including interests in a high-gradeiodine, lithium & bromine brine project located in Utah,USA.
Voyageur is moving forward with its business plan ofbecoming the only fully integrated company in the radio-contrastmedical field, by controlling all primary input costs under the mottoof:
"From theEarth to the Bottle"
www.voyageurpharmaceuticals.ca
For Further Media Information or toset up an interview, please contact:
Brent Willis
President & CEO
Ron Love
CFO
T 403.818.6086
Reader Advisory
Neither the TSXVnor its Regulation Services Provider (as that term is defined in thepolicies of the TSXV) accepts responsibility for the adequacy oraccuracy of this news release.
Copyright (c) 2020 TheNewswire - All rights reserved.